Sridhar Vempati

1.8k total citations · 1 hit paper
9 papers, 1.3k citations indexed

About

Sridhar Vempati is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Sridhar Vempati has authored 9 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Sridhar Vempati's work include Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Epigenetics and DNA Methylation (3 papers). Sridhar Vempati is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Epigenetics and DNA Methylation (3 papers). Sridhar Vempati collaborates with scholars based in Germany, United States and Canada. Sridhar Vempati's co-authors include Andrew L. Kung, Scott A. Armstrong, Andrei V. Krivtsov, Amit Sinha, Joerg Faber, Victoria M. Richon, Kathrin M. Bernt, Roy M. Pollock, Nan Zhu and Zhaohui Feng and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Cell.

In The Last Decade

Sridhar Vempati

9 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L

2011 642 citations Kathrin M. Bernt, Nan Zhu et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sridhar Vempati Germany	7	1.1k	686	174	163	104	9	1.3k
Stefan Deneberg Sweden	13	596 0.6×	560 0.8×	125 0.7×	109 0.7×	78 0.8×	26	782
Juan A. Castillejo Spain	15	552 0.5×	367 0.5×	115 0.7×	153 0.9×	138 1.3×	17	906
Sandra Heesch Germany	15	382 0.4×	368 0.5×	81 0.5×	376 2.3×	104 1.0×	21	777
Pauline Schneider Netherlands	18	618 0.6×	512 0.7×	93 0.5×	576 3.5×	143 1.4×	41	1.1k
Corrado Caslini United States	14	746 0.7×	229 0.3×	48 0.3×	136 0.8×	139 1.3×	20	937
Yebin Ahn United States	3	389 0.4×	251 0.4×	64 0.4×	238 1.5×	102 1.0×	4	601
Linda Holmfeldt United States	8	393 0.4×	275 0.4×	64 0.4×	281 1.7×	141 1.4×	14	740
Christian Hurtz United States	10	246 0.2×	258 0.4×	107 0.6×	162 1.0×	115 1.1×	32	607
Gorica Nikoloski Netherlands	7	575 0.5×	369 0.5×	161 0.9×	36 0.2×	47 0.5×	8	717
David Mbangkollo United States	6	376 0.4×	369 0.5×	77 0.4×	184 1.1×	54 0.5×	8	631

Countries citing papers authored by Sridhar Vempati

Since Specialization

Citations

This map shows the geographic impact of Sridhar Vempati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridhar Vempati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridhar Vempati more than expected).

Fields of papers citing papers by Sridhar Vempati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sridhar Vempati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridhar Vempati. The network helps show where Sridhar Vempati may publish in the future.

Co-authorship network of co-authors of Sridhar Vempati

This figure shows the co-authorship network connecting the top 25 collaborators of Sridhar Vempati. A scholar is included among the top collaborators of Sridhar Vempati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sridhar Vempati. Sridhar Vempati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Akbulut, Özge, Özge Saatci, Chaemin Lim, et al.. (2025). Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy. Bioorganic Chemistry. 156. 108204–108204. 1 indexed citations

2.

Dumbrava, Ecaterina E., et al.. (2024). A first-in-human, phase 1 study evaluating oral TACC3 inhibitor, AO-252, in advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS3176–TPS3176. 1 indexed citations

3.

Stubbs, Matthew C., Won-Il Kim, Tina Davis, et al.. (2015). Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL. Clinical Cancer Research. 21(10). 2348–2358. 59 indexed citations

4.

Bernt, Kathrin M., Nan Zhu, Amit Sinha, et al.. (2011). MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L. Cancer Cell. 20(1). 66–78. 642 indexed citations breakdown →

5.

Reindl, Carola, Hilmar Quentmeier, Konstantin Petropoulos, et al.. (2009). CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes. Clinical Cancer Research. 15(7). 2238–2247. 89 indexed citations

6.

Vempati, Sridhar, Carola Reindl, Konstantin Petropoulos, et al.. (2008). Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591. Clinical Cancer Research. 14(14). 4437–4445. 23 indexed citations

7.

Krivtsov, Andrei V., Zhaohui Feng, Madeleine E. Lemieux, et al.. (2008). H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias. Cancer Cell. 14(5). 355–368. 396 indexed citations

8.

Vempati, Sridhar, Carola Reindl, Martin Dugas, et al.. (2007). Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential. Blood. 110(2). 686–694. 18 indexed citations

9.

Reindl, Carola, Ksenia Bagrintseva, Sridhar Vempati, et al.. (2006). Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML. Blood. 107(9). 3700–3707. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact